As a critical pharmaceutical ingredient, Levonorgestrel must comply with international pharmacopoeia standards such as USP (United States Pharmacopeia), BP (British Pharmacopeia), or EP (European Pharmacopoeia). Buyers must ensure the supplier holds a valid GMP (Good Manufacturing Practice) certificate and can provide a COA (Certificate of Analysis) for every batch. For regulated markets, a DMF (Drug Master File) or CEP (Certificate of Suitability) is highly recommended to ensure the manufacturing process meets stringent safety and purity requirements.